These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 7675521
1. Role of prostaglandin in the formation of osteoclasts induced by capsular-like polysaccharide antigen of Actinobacillus actinomycetemcomitans strain Y4. Ueda N, Nishihara T, Ishihara Y, Amano K, Kuroyanagi T, Noguchi T. Oral Microbiol Immunol; 1995 Apr; 10(2):69-75. PubMed ID: 7675521 [Abstract] [Full Text] [Related]
2. Actinobacillus actinomycetemcomitans Y4 capsular-polysaccharide-like polysaccharide promotes osteoclast-like cell formation by interleukin-1 alpha production in mouse marrow cultures. Nishihara T, Ueda N, Amano K, Ishihara Y, Hayakawa H, Kuroyanagi T, Ohsaki Y, Nagata K, Noguchi T. Infect Immun; 1995 May; 63(5):1893-8. PubMed ID: 7729899 [Abstract] [Full Text] [Related]
3. Involvement of prostaglandin E2 and interleukin-1 alpha in the differentiation and survival of osteoclasts induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4. Ueda N, Koide M, Ohguchi M, Ishihara Y, Noguchi T, Okahashi N, Nishihara T. J Periodontal Res; 1998 Nov; 33(8):509-16. PubMed ID: 9879525 [Abstract] [Full Text] [Related]
4. Role of interleukin-1 and prostaglandin in in vitro bone resorption induced by Actinobacillus actinomycetemcomitans lipopolysaccharide. Ishihara Y, Nishihara T, Maki E, Noguchi T, Koga T. J Periodontal Res; 1991 May; 26(3 Pt 1):155-60. PubMed ID: 1830617 [Abstract] [Full Text] [Related]
5. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice. Mizutani H, Ishihara Y, Izawa A, Fujihara Y, Kobayashi S, Gotou H, Okabe E, Takeda H, Ozawa Y, Kamiya Y, Kamei H, Kikuchi T, Yamamoto G, Mitani A, Nishihara T, Noguchi T. J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622 [Abstract] [Full Text] [Related]
7. Anti-proliferative capsular-like polysaccharide antigen from Actinobacillus actinomycetemcomitans induces apoptotic cell death in mouse osteoblastic MC3T3-E1 cells. Yamamoto S, Mogi M, Kinpara K, Ishihara Y, Ueda N, Amano K, Nishihara T, Noguchi T, Togari A. J Dent Res; 1999 Jun; 78(6):1230-7. PubMed ID: 10371246 [Abstract] [Full Text] [Related]
8. Inhibition of experimental bone resorption and osteoclast formation and survival by 2-aminoethanesulphonic acid. Koide M, Okahashi N, Tanaka R, Kazuno K, Shibasaki K, Yamazaki Y, Kaneko K, Ueda N, Ohguchi M, Ishihara Y, Noguchi T, Nishihara T. Arch Oral Biol; 1999 Sep; 44(9):711-9. PubMed ID: 10471155 [Abstract] [Full Text] [Related]
9. The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway. Akatsu T, Ono K, Katayama Y, Tamura T, Nishikawa M, Kugai N, Yamamoto M, Nagata N. J Bone Miner Res; 1998 Mar; 13(3):400-8. PubMed ID: 9525340 [Abstract] [Full Text] [Related]
10. Actinobacillus actinomycetemcomitans Y4 capsular polysaccharide induces IL-1beta mRNA expression through the JNK pathway in differentiated THP-1 cells. Iwata T, Mitani A, Ishihara Y, Tanaka S, Yamamoto G, Kikuchi T, Naganawa T, Matsumura Y, Suga T, Koide M, Sobue T, Suzuki T, Noguchi T. Clin Exp Immunol; 2005 Aug; 141(2):261-9. PubMed ID: 15996190 [Abstract] [Full Text] [Related]
12. Mouse interleukin-1 receptor antagonist induced by Actinobacillus actinomycetemcomitans lipopolysaccharide blocks the effects of interleukin-1 on bone resorption and osteoclast-like cell formation. Nishihara T, Ohsaki Y, Ueda N, Saito N, Mundy GR. Infect Immun; 1994 Feb; 62(2):390-7. PubMed ID: 8300200 [Abstract] [Full Text] [Related]
13. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity. Collin-Osdoby P, Oursler MJ, Rothe L, Webber D, Anderson F, Osdoby P. J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630 [Abstract] [Full Text] [Related]
16. Construction of mutants of Actinobacillus actinomycetemcomitans defective in serotype b-specific polysaccharide antigen by insertion of transposon Tn916. Sato S, Takamatsu N, Okahashi N, Matsunoshita N, Inoue M, Takehara T, Koga T. J Gen Microbiol; 1992 Jun; 138(6):1203-9. PubMed ID: 1326593 [Abstract] [Full Text] [Related]
17. Role of the capsular polysaccharide-like serotype-specific antigen in resistance of Actinobacillus actinomycetemcomitans to phagocytosis by human polymorphonuclear leukocytes. Yamaguchi N, Kawasaki M, Yamashita Y, Nakashima K, Koga T. Infect Immun; 1995 Dec; 63(12):4589-94. PubMed ID: 7591110 [Abstract] [Full Text] [Related]
18. Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures. Ikegame M, Rakopoulos M, Martin TJ, Moseley JM, Findlay DM. J Bone Miner Res; 1996 Apr; 11(4):456-65. PubMed ID: 8992876 [Abstract] [Full Text] [Related]
19. Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures. Kawaguchi H, Chikazu D, Nakamura K, Kumegawa M, Hakeda Y. J Bone Miner Res; 2000 Mar; 15(3):466-73. PubMed ID: 10750561 [Abstract] [Full Text] [Related]
20. Differentiation of the serotype b and species-specific antigens of Actinobacillus actinobacillus actinomycetemcomitans recognized by monoclonal antibodies. McArthur WP, Stroup S, McClellan S, Leung KP. Oral Microbiol Immunol; 1996 Aug; 11(4):209-19. PubMed ID: 9002872 [Abstract] [Full Text] [Related] Page: [Next] [New Search]